Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/1997
10/16/1997WO1997037998A2 Neuropeptide y receptor y5 and nucleic acid sequence
10/16/1997WO1997037995A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines
10/16/1997WO1997037992A2 Spiro[cyclopent[b]indole-piperidines] and n-phenyl-hydrazon intermediates for their preparation, both being acetylcholinesterase and mao inhibitors
10/16/1997WO1997037988A1 Acylated n-hydroxy methyl thalidomide prodrugs with immunomodulator action
10/16/1997WO1997037983A1 α1-ADRENERGIC RECEPTOR ANTAGONISTS
10/16/1997WO1997037979A1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use
10/16/1997WO1997037977A1 Substituted quinoline derivatives with antiviral action
10/16/1997WO1997037975A1 Carboxylic acid derivatives with an aggregation-inhibiting action
10/16/1997WO1997037974A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997WO1997037973A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997WO1997037972A1 Novel vitamin d analogues
10/16/1997WO1997037970A1 Phenylalkylcarboxylic acid derivatives
10/16/1997WO1997037969A1 Tryptase inhibitor and novel guanidino derivatives
10/16/1997WO1997037967A1 Calcilytic compounds
10/16/1997WO1997037966A1 Quaternary cytofectins
10/16/1997WO1997037689A2 Denaturants for sympathomimetic amine salts
10/16/1997WO1997037688A2 Pharmaceutical combination containing a compound having angiotensin ii and antagonistic activity
10/16/1997WO1997037684A1 Method for gene transfer to the central nervous system
10/16/1997WO1997037681A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997WO1997037678A1 Drug for the treatment of tumours
10/16/1997WO1997037676A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997WO1997037668A1 Use of macrolide antibiotics for nonsurgical female sterilization and endometrial ablation
10/16/1997WO1997037667A1 Use of an a1 adenosine receptor agonist to treat cerebral ischaemia
10/16/1997WO1997037666A1 Use of phosphinyloxyalkyl and phosphonamidoalkyl derivatives of cyclopentane(ene) as therapeutic agents
10/16/1997WO1997037665A1 Method of treating heart failure with endothelin antagonists
10/16/1997WO1997037664A2 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/16/1997WO1997037663A1 Use of dehydroepiandrosterone for the treatment of addictions
10/16/1997WO1997037662A1 5-ANDROSTENE 3β,17α DIOL AS AN INHIBITOR OF TUMOR GROWTH
10/16/1997WO1997037661A1 Preventive and remedy for viral infections
10/16/1997WO1997037660A1 METHOD FOR TREATING $i(MYCOBACTERIUM TUBERCULOSIS)
10/16/1997WO1997037659A1 Transdermal delivery device for azapirone compounds
10/16/1997WO1997037658A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents
10/16/1997WO1997037657A1 Anti-hiv composition containing imidazole derivative
10/16/1997WO1997037656A1 Anticachectic composition
10/16/1997WO1997037655A1 αvβ3 ANTAGONISTS
10/16/1997WO1997037654A1 Use of photopheresis in the treatment of chronic infection by hepatitis c virus
10/16/1997WO1997037653A1 Injection formulations of avermectins and milbemycins based on castor oil
10/16/1997WO1997037652A1 Methods of providing neuroprotection
10/16/1997WO1997037651A1 Method for producing a drug (trecresan) with nootropic activity
10/16/1997WO1997037650A1 Remedies for retinal diseases
10/16/1997WO1997037649A1 Method of reducing nephrotoxicity
10/16/1997WO1997037648A1 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
10/16/1997WO1997037647A1 Utilisation des derives 2,5-dihydroxybenzenesulfoniques pour la fabrication de medicaments destines a la normalisation de la fonction endotheliale, pour le traitement de la dysfonction sexuelle et des complications vasculaires du diabete, ainsi que des troubles vasculaires d'origine endotheliale
10/16/1997WO1997037645A1 Correction of genetic defects using chemical chaperones
10/16/1997WO1997037644A1 Treatment of a hemoglobinopathy
10/16/1997WO1997037642A1 Estradiol and progesterone-based medicament
10/16/1997WO1997037641A1 Oral coated active drugs
10/16/1997WO1997037637A1 Liposome-based topical vitamin d formulation
10/16/1997WO1997037631A2 Chemotherapeutic veterinary drug containing oxytetracycline, sulfadimidine and neomycin
10/16/1997WO1997037630A2 Spiro(2h-1-benzopyran-2,4'-piperidine)-4(3h)-one derivatives, acid addition salts thereof and pharmaceutical compositions containing them
10/16/1997WO1997037549A1 Substance containing health-promoting component and process for the production thereof
10/16/1997WO1997037542A1 Gene therapy for proliferative vitreoretinopathy
10/16/1997WO1997037537A1 Corneal storage fluid comprised of hyaluronic acid
10/16/1997WO1997032588A3 Combination of dehydroepiandrosterone and aromatase inhibitors and use of this combination to produce a medicament for treating relative and absolute androgen deficiency in men
10/16/1997WO1997030714A3 Topical pharmaceutical composition containing heparin
10/16/1997WO1997030178A3 Diagnosing trinucleotide repeat diseases and genes involved therein
10/16/1997WO1997029758A3 Use of azithromycin and tinidazole for the eradication of helicobacter pylori
10/16/1997WO1997028826A3 Contraceptive release systems with antibacterial and/or antiviral effect
10/16/1997WO1997025071A3 Immunoconjugate for the treatment of aids
10/16/1997WO1997024138A3 Medical use of proteases
10/16/1997WO1997024125A3 Injectable pharmaceutical composition comprising ursodesoxycholic acid or tauroursodesoxycholic acid, a strong base and tromethamol
10/16/1997WO1997022619A3 INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
10/16/1997DE19614542A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use
10/16/1997DE19614534A1 Neue Carbonsäurederivate, ihre Herstellung und Verwendung New carboxylic acid derivatives, their preparation and use
10/16/1997DE19614533A1 Neue alpha-Hydroxysäurederivate, ihre Herstellung und Verwendung New alpha-hydroxy-acid derivatives, their preparation and use
10/16/1997DE19614204A1 Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung Carboxylic acid derivatives, medicaments containing these compounds, their use and processes for their preparation
10/16/1997DE19613972A1 Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl Injection formulations of avermectins and milbemycins based on castor oil
10/16/1997CA2650637A1 Pharmaceutical composition containing angiotensin ii antagonist
10/16/1997CA2578825A1 5-androstene 3.beta., 17.alpha. diol as an inhibitor of tumor growth
10/16/1997CA2391030A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines
10/16/1997CA2252086A1 6-substituted amino-4-oxa-1-azabicyclo¬3,2,0|heptan-7-one derivatives as cysteine protease inhibitors
10/16/1997CA2251603A1 Gene family associated with neurosensory defects
10/16/1997CA2251579A1 Methods of providing neuroprotection
10/16/1997CA2251468A1 Phenylalkylcarboxylic acid derivatives
10/16/1997CA2251308A1 New quinazoline-4-amino-2-(piperidine-1-yl-4-substituted) derivatives having anti-hypertensive activity, a method for their preparation and their pharmaceutical use
10/16/1997CA2251078A1 Gene therapy for proliferative vitreoretinopathy
10/16/1997CA2251072A1 Calixpyrroles, calixpyridinopyrroles and calixpyridines
10/16/1997CA2251032A1 Corneal storage fluid comprised of hyaluronic acid
10/16/1997CA2251022A1 Oral coated active drugs
10/16/1997CA2251017A1 .alpha.v.beta.3 antagonists
10/16/1997CA2251009A1 Medicament for optimising mucosal viscosity and stimulating intestinal function
10/16/1997CA2250898A1 Use of derivatives of tetrahydro-beta-carbolines as antimetastatic agents
10/16/1997CA2250874A1 Use of 7 alpha-substituted steroids to treat neuropsychiatric, immune or endocrine disorders
10/16/1997CA2250868A1 Human cachexia associated protein
10/16/1997CA2250860A1 Polynucleotides encoding secreted proteins
10/16/1997CA2250839A1 Drug for the treatment of tumours
10/16/1997CA2250835A1 Novel ectoparasite saliva proteins and apparatus to collect such proteins
10/16/1997CA2250780A1 Correction of genetic defects using chemical chaperones
10/16/1997CA2250755A1 Use of benzonaphthalene derivatives to make medicaments for treating diseases of the central nervous system
10/16/1997CA2250722A1 Neuropeptide y receptor y5 and nucleic acid sequence
10/16/1997CA2250525A1 Method for detecting a target compound using a nucleic acid ligand
10/16/1997CA2250268A1 Extracellular/epidermal growth factor hcaba58x
10/16/1997CA2249213A1 Extracellular/epidermal growth factor-like protein
10/16/1997CA2248949A1 Novel furan diarylmethylidene derivatives, method for their preparation and therapeutical uses thereof
10/16/1997CA2248082A1 Peptidyl compounds having mmp and tnf- liberation inhibitory activity
10/16/1997CA2248070A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997CA2247964A1 Peptidyl compounds having mmp and tnf inhibitory activity
10/16/1997CA2244860A1 Carboxylic acid derivatives with an aggregation-inhibiting action
10/16/1997CA2224212A1 Novel spiro (2h-1-benzopyran-2,4'-piperidine)- 4(3h)-one derivatives, acid addition salts thereof and pharmaceutical compositions containing them
10/15/1997EP0801135A1 Enzymatic resolution of endo-bicyclo (2.2.1)heptan-2-ol
1 ... 6736 6737 6738 6739 6740 6741 6742 6743 6744 6745 6746 6747 6748 6749 6750 6751 6752 6753 6754 6755 6756 ... 7860